Robust population prevalence studies for non-IgE mediated gastrointestinal food allergies are needed but at present numerous logistical challenges, related to the delayed nature of symptoms, which makes a double blind placebo controlled food challenge, the gold standard for diagnosis of food allergy, very difficult to perform. The gene discussed is IGHE; the disease is food allergy.